MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

6. Hot: Transcatheter Mitral Valve Replacement

    Arrow  backNeovasc Tiara

6. Hot: Transcatheter Mitral Valve Replacement

With TAVR generating so much buzz, transcatheter mitral valve replacement devices appear to be the next cardiovascular technology. Abbott Laboratories, Edwards Lifesciences, and Medtronic each poured hundreds of millions of dollars into acquiring early-stage companies with technology in the space. Mitral valve disease is the most prevalent valve disease in the world, according to Abbott, which expects a multibillion-dollar market for the technology over the next 10 years. Ultimately, the market share size for mitral valve replacement technology could be double the size of the TAVR market, owing to the larger patient population. The Neovasc Tiara technology is shown here. 

Continue >>

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.